Bayesian adaptive trial designs for precision medicine
Update: 2017-07-31
Description
Dr Lee speaks with ecancer at WIN 2017 about changing attitudes and designs of trial design to a Bayesian framework, which integrates serial data collection into the assessment of patient response.
He notes 20% of trials conducted at M.D. Anderson incorporate some elements of Bayesian design, including the I-SPY 2 trial.
He notes 20% of trials conducted at M.D. Anderson incorporate some elements of Bayesian design, including the I-SPY 2 trial.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
